2025-2031 Global Veterinary mRNA Vaccines Industry Research & Trends Analysis Report- YH Research

Home > Reports >Pharma & Healthcare > 2025-2031 Global Veterinary mRNA Vaccines Industry Research & Trends Analysis Report

2025-2031 Global Veterinary mRNA Vaccines Industry Research & Trends Analysis Report

Publication Date: 2025-11-04
Report Id: 1968170
Industry: Pharma & Healthcare
Report Page: 128
Chart: 132

PDF Download

Publication Date: 2025-11-04
Report Id: 1968170
Industry: Pharma & Healthcare
Report Page: 128
Chart: 132

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of Veterinary mRNA Vaccines
1.2 Global Veterinary mRNA Vaccines Market Size and Forecast
1.3 China Veterinary mRNA Vaccines Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Veterinary mRNA Vaccines Share in Global Market, 2020-2031
1.4.2 Veterinary mRNA Vaccines Market Size: China VS Global, 2020-2031
1.5 Veterinary mRNA Vaccines Market Dynamics
1.5.1 Veterinary mRNA Vaccines Market Drivers
1.5.2 Veterinary mRNA Vaccines Market Restraints
1.5.3 Veterinary mRNA Vaccines Industry Trends
1.5.4 Veterinary mRNA Vaccines Industry Policy

2 Competitive Landscape by Company
2.1 Global Veterinary mRNA Vaccines Revenue by Company, 2020-2025
2.2 Global Veterinary mRNA Vaccines Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Veterinary mRNA Vaccines Concentration Ratio
2.4 Global Veterinary mRNA Vaccines Mergers & Acquisitions, Expansion Plans
2.5 Global Veterinary mRNA Vaccines Manufacturers Product Type
2.6 Global Geographic Distribution of Veterinary mRNA Vaccines Companies

3 China Competitive Situation by Company
3.1 China Veterinary mRNA Vaccines Revenue by Company, 2020-2025
3.2 China Veterinary mRNA Vaccines Veterinary mRNA Vaccines Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Veterinary mRNA Vaccines Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 Veterinary mRNA Vaccines Industry Chain
4.2 Veterinary mRNA Vaccines Upstream Analysis
4.3 Veterinary mRNA Vaccines Midstream Analysis
4.4 Veterinary mRNA Vaccines Downstream Analysis

5 Sights by Type
5.1 Veterinary mRNA Vaccines Classification by Type
5.1.1 Non-replicating mRNA Vaccine
5.1.2 Self-amplifying mRNA Vaccine
5.2 by Type, Global Veterinary mRNA Vaccines Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Veterinary mRNA Vaccines Market Size, 2020-2031

6 Sights by Company Type
6.1 Veterinary mRNA Vaccines Classification by Company Type
6.1.1 Vaccine Developers
6.1.2 Drug Manufacturers
6.2 by Company Type, Global Veterinary mRNA Vaccines Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Company Type, Global Veterinary mRNA Vaccines Market Size, 2020-2031

7 Sights by Administration Method
7.1 Veterinary mRNA Vaccines Classification by Administration Method
7.1.1 Injectable Drug Administration
7.1.2 Non-invasive Drug Administration
7.2 by Administration Method, Global Veterinary mRNA Vaccines Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Administration Method, Global Veterinary mRNA Vaccines Market Size, 2020-2031

8 Sights by Application
8.1 Veterinary mRNA Vaccines Segment by Application
8.1.1 Pigs
8.1.2 Poultry
8.1.3 Ruminants
8.1.4 Companion Animals
8.2 by Application, Global Veterinary mRNA Vaccines Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by Application, Global Veterinary mRNA Vaccines Market Size, 2020-2031

9 Sights by Region
9.1 By Region, Global Veterinary mRNA Vaccines Market Size, 2020 VS 2024 VS 2031
9.2 By Region, Global Veterinary mRNA Vaccines Market Size, 2020-2031
9.3 North America
9.3.1 North America Veterinary mRNA Vaccines Market Size & Forecasts, 2020-2031
9.3.2 By Country, North America Veterinary mRNA Vaccines Market Size Market Share
9.4 Europe
9.4.1 Europe Veterinary mRNA Vaccines Market Size & Forecasts, 2020-2031
9.4.2 By Country, Europe Veterinary mRNA Vaccines Market Size Market Share
9.5 Asia Pacific
9.5.1 Asia Pacific Veterinary mRNA Vaccines Market Size & Forecasts, 2020-2031
9.5.2 By Country/Region, Asia Pacific Veterinary mRNA Vaccines Market Size Market Share
9.6 South America
9.6.1 South America Veterinary mRNA Vaccines Market Size & Forecasts, 2020-2031
9.6.2 By Country, South America Veterinary mRNA Vaccines Market Size Market Share
9.7 Middle East & Africa

10 Sights by Country Level
10.1 By Country, Global Veterinary mRNA Vaccines Market Size & CAGR，2020 VS 2024 VS 2031
10.2 By Country, Global Veterinary mRNA Vaccines Market Size, 2020-2031
10.3 United States
10.3.1 United States Veterinary mRNA Vaccines Market Size, 2020-2031
10.3.2 By Company, United States Veterinary mRNA Vaccines Revenue Market Share, 2024
10.3.3 by Type, United States Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.3.4 by Application, United States Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.4 Europe
10.4.1 Europe Veterinary mRNA Vaccines Market Size, 2020-2031
10.4.2 By Company, Europe Veterinary mRNA Vaccines Revenue Market Share, 2024
10.4.3 by Type, Europe Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.4.4 by Application, Europe Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.5 China
10.5.1 China Veterinary mRNA Vaccines Market Size, 2020-2031
10.5.2 By Company, China Veterinary mRNA Vaccines Revenue Market Share, 2024
10.5.3 by Type, China Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.5.4 by Application, China Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.6 Japan
10.6.1 Japan Veterinary mRNA Vaccines Market Size, 2020-2031
10.6.2 By Company, Japan Veterinary mRNA Vaccines Revenue Market Share, 2024
10.6.3 by Type, Japan Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.6.4 by Application, Japan Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.7 South Korea
10.7.1 South Korea Veterinary mRNA Vaccines Market Size, 2020-2031
10.7.2 By Company, South Korea Veterinary mRNA Vaccines Revenue Market Share, 2024
10.7.3 by Type, South Korea Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.7.4 by Application, South Korea Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.8 Southeast Asia
10.8.1 Southeast Asia Veterinary mRNA Vaccines Market Size, 2020-2031
10.8.2 By Company, Southeast Asia Veterinary mRNA Vaccines Revenue Market Share, 2024
10.8.3 by Type, Southeast Asia Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.8.4 by Application, Southeast Asia Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.9 India
10.9.1 India Veterinary mRNA Vaccines Market Size, 2020-2031
10.9.2 By Company, India Veterinary mRNA Vaccines Revenue Market Share, 2024
10.9.3 by Type, India Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.9.4 by Application, India Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.10 Middle East & Africa
10.10.1 Middle East & Africa Veterinary mRNA Vaccines Market Size, 2020-2031
10.10.2 By Company, Middle East & Africa Veterinary mRNA Vaccines Revenue Market Share, 2024
10.10.3 by Type, Middle East & Africa Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031
10.10.4 by Application, Middle East & Africa Veterinary mRNA Vaccines Revenue Market Share, 2024 VS 2031

11 Company Profile
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Information, Head Office, Market Area, and Industry Position
11.1.2 Merck Animal Health Company Profile and Main Business
11.1.3 Merck Animal Health Veterinary mRNA Vaccines Models, Specifications, and Application
11.1.4 Merck Animal Health Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.1.5 Merck Animal Health Recent Developments
11.2 Ceva Animal Health
11.2.1 Ceva Animal Health Company Information, Head Office, Market Area, and Industry Position
11.2.2 Ceva Animal Health Company Profile and Main Business
11.2.3 Ceva Animal Health Veterinary mRNA Vaccines Models, Specifications, and Application
11.2.4 Ceva Animal Health Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.2.5 Ceva Animal Health Recent Developments
11.3 Tiba Biotechnology
11.3.1 Tiba Biotechnology Company Information, Head Office, Market Area, and Industry Position
11.3.2 Tiba Biotechnology Company Profile and Main Business
11.3.3 Tiba Biotechnology Veterinary mRNA Vaccines Models, Specifications, and Application
11.3.4 Tiba Biotechnology Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.3.5 Tiba Biotechnology Recent Developments
11.4 Jinyu Biotechnology
11.4.1 Jinyu Biotechnology Company Information, Head Office, Market Area, and Industry Position
11.4.2 Jinyu Biotechnology Company Profile and Main Business
11.4.3 Jinyu Biotechnology Veterinary mRNA Vaccines Models, Specifications, and Application
11.4.4 Jinyu Biotechnology Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.4.5 Jinyu Biotechnology Recent Developments
11.5 Harbin Enwei Biological Pharmaceutical
11.5.1 Harbin Enwei Biological Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.5.2 Harbin Enwei Biological Pharmaceutical Company Profile and Main Business
11.5.3 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Models, Specifications, and Application
11.5.4 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.5.5 Harbin Enwei Biological Pharmaceutical Recent Developments
11.6 Shanghai Rnacure Biopharma
11.6.1 Shanghai Rnacure Biopharma Company Information, Head Office, Market Area, and Industry Position
11.6.2 Shanghai Rnacure Biopharma Company Profile and Main Business
11.6.3 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Models, Specifications, and Application
11.6.4 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.6.5 Shanghai Rnacure Biopharma Recent Developments
11.7 Ruipu Biotechnology
11.7.1 Ruipu Biotechnology Company Information, Head Office, Market Area, and Industry Position
11.7.2 Ruipu Biotechnology Company Profile and Main Business
11.7.3 Ruipu Biotechnology Veterinary mRNA Vaccines Models, Specifications, and Application
11.7.4 Ruipu Biotechnology Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.7.5 Ruipu Biotechnology Recent Developments
11.8 Jiangsu Synthgene Biotechnology
11.8.1 Jiangsu Synthgene Biotechnology Company Information, Head Office, Market Area, and Industry Position
11.8.2 Jiangsu Synthgene Biotechnology Company Profile and Main Business
11.8.3 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Models, Specifications, and Application
11.8.4 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.8.5 Jiangsu Synthgene Biotechnology Recent Developments
11.9 Genvax Technologies
11.9.1 Genvax Technologies Company Information, Head Office, Market Area, and Industry Position
11.9.2 Genvax Technologies Company Profile and Main Business
11.9.3 Genvax Technologies Veterinary mRNA Vaccines Models, Specifications, and Application
11.9.4 Genvax Technologies Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.9.5 Genvax Technologies Recent Developments
11.10 Shanghai Shen Lian Biomedical
11.10.1 Shanghai Shen Lian Biomedical Company Information, Head Office, Market Area, and Industry Position
11.10.2 Shanghai Shen Lian Biomedical Company Profile and Main Business
11.10.3 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Models, Specifications, and Application
11.10.4 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.10.5 Shanghai Shen Lian Biomedical Recent Developments
11.11 Suzhou Kerui Meide Biomedical Technology
11.11.1 Suzhou Kerui Meide Biomedical Technology Company Information, Head Office, Market Area, and Industry Position
11.11.2 Suzhou Kerui Meide Biomedical Technology Company Profile and Main Business
11.11.3 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Models, Specifications, and Application
11.11.4 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Revenue and Gross Margin, 2020-2025
11.11.5 Suzhou Kerui Meide Biomedical Technology Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for Veterinary mRNA Vaccines should grow from US$ 86.15 million in 2024 to US$ 33699 million by 2031, with a CAGR of 38.6% for the period of 2025-2031.

Veterinary mRNA vaccines are a new generation of vaccines designed to protect animals from infectious diseases using messenger RNA (mRNA) technology. These vaccines work by delivering synthetic mRNA into animal cells, instructing them to produce specific antigens that trigger an immune response without using live pathogens. Compared to traditional vaccines, mRNA vaccines offer advantages such as faster development, adaptability to emerging diseases, and the ability to target multiple pathogens. They are being developed for livestock, poultry, and companion animals to combat diseases like avian influenza, swine fever, and canine influenza, improving animal health and food security.

Veterinary mRNA Vaccines

According to YH Research, the global market for Veterinary mRNA Vaccines should grow from US$ 86.15 million in 2024 to US$ 33699 million by 2031, with a CAGR of 38.6% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Compared to traditional vaccines, mRNA vaccines have demonstrated revolutionary advantages in the field of animal health. This technology introduces mRNA sequences encoding specific antigens of pathogens into animal cells, directing the cells to synthesize antigen proteins and thus stimulating an immune response. This mechanism avoids the production complexities of traditional inactivated or live attenuated vaccines while possessing the ability to rapidly respond to emerging diseases. This technological characteristic is particularly important in the context of frequent outbreaks of major animal diseases such as African swine fever and avian influenza. The animal mRNA vaccine market is in the early stages of explosive growth, with the first peak in market launches expected between 2026 and 2028.

In terms of product type, animal mRNA vaccines mainly fall into two categories: non-replicating mRNA vaccines and self-replicating mRNA vaccines. Non-replicating mRNA vaccines have a simple structure, flexible sequence design, rapid antigen replacement (e.g., to address viral mutations), mature production processes (in vitro transcription + LNP encapsulation), no risk of genome integration, and no infectious particles; the toxicity of LNP delivery systems is controllable, and clinical adverse reactions are mainly mild to moderate (e.g., local pain, fever). Currently, most domestic companies pursue rapid market launch and development of multivalent vaccines, which are primarily non-replicating mRNA vaccines. In contrast, self-amplifying mRNA vaccines use replicase to amplify the mRNA copy number, and ng-level doses can induce a strong immune response (antibody titers increased more than 10-fold in animal experiments). Antigen expression lasts for several weeks, and a single dose can provide long-term protection.

This report aims to provide a comprehensive study of the global market for Veterinary mRNA Vaccines. Report Highlights:
(1) Global Veterinary mRNA Vaccines market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global Veterinary mRNA Vaccines market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China Veterinary mRNA Vaccines market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global Veterinary mRNA Vaccines segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Veterinary mRNA Vaccines segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Veterinary mRNA Vaccines industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Non-replicating mRNA Vaccine
    Self-amplifying mRNA Vaccine

Market segment by Company Type, covers
    Vaccine Developers
    Drug Manufacturers

Market segment by Administration Method, covers
    Injectable Drug Administration
    Non-invasive Drug Administration

Market segment by Application, can be divided into
    Pigs
    Poultry
    Ruminants
    Companion Animals

Market segment by players, this report covers
    Merck Animal Health
    Ceva Animal Health
    Tiba Biotechnology
    Jinyu Biotechnology
    Harbin Enwei Biological Pharmaceutical
    Shanghai Rnacure Biopharma
    Ruipu Biotechnology
    Jiangsu Synthgene Biotechnology
    Genvax Technologies
    Shanghai Shen Lian Biomedical
    Suzhou Kerui Meide Biomedical Technology